L’obésité

A healthy BMI falls between 18.5 and 24.9, calculated by dividing weight in kilograms by height in meters squared. Obesity is diagnosed when BMI reaches 30 or higher. This numerical classification helps identify individuals at increased health risk from excessive adipose tissue accumulation.

Initially, excess dietary calories convert into triglycerides stored in adipocytes, causing individual fat cells to enlarge. Once adipocytes reach their size limit, they multiply rather than expand further, particularly in extreme obesity. This proliferation increases total fat storage capacity and contributes to progressive weight gain.

Obese adipocytes express more alpha-adrenergic receptors and release inflammatory cytokines that promote insulin resistance. Additionally, their highly efficient lipoprotein lipase breaks down triglycerides more readily, facilitating fat storage. This combination of altered receptor expression and chronic low-grade systemic inflammation disrupts normal glucose metabolism.

Obesity increases risk for type 2 diabetes mellitus, atherosclerosis, hypertension, heart disease, and osteoarthritis. These complications arise from insulin resistance, chronic inflammation, and altered lipid metabolism. The metabolic dysfunction characteristic of obesity creates multiple pathways for cardiovascular and metabolic disease development.

Yes, some obese individuals consume normal calorie amounts but possess metabolic traits promoting fat accumulation. Enhanced lipoprotein lipase activity, altered receptor expression favoring storage, and inflammatory cytokine release can drive obesity independent of overeating. Genetic predisposition and metabolic efficiency variations explain why calorie intake alone does not determine obesity development.

Obesity results from multiple causes including overeating during childhood, genetic predisposition, and enhanced fat storage efficiency. Hypothalamic tumors affecting food intake regulation can also trigger obesity. The condition is multifactorial, with many contributing mechanisms remaining incompletely understood, making prevention and treatment complex.

Endothelial lipoprotein lipase is more active in abdominal fat than hip fat, making abdominal fat accumulation a greater risk factor for elevated cholesterol levels and cardiovascular disease. This regional difference in enzyme activity and metabolic activity explains why central obesity poses higher health risks than peripheral fat distribution patterns.